|
1D0G
CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL
Deposited 1999-09-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN RESIDUES 1-130
Chain S
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN RESIDUES 1-130
Chain T
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN RESIDUES 1-130
|
Not recorded
|
ZN ZINC ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;15% Peg8K, 10% ethylene glycol, 0.2M ammonium sulface, 0.1M Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP,
temperature 19K
|
Resolution 2.40 Å
R-free 0.267
|
|
1DU3
Crystal structure of TRAIL-SDR5
Deposited 2000-01-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain B
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain C
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 4.6;295 K;PEG 1000, Sodium Acetate, Sodium Chloride, pH 4.6, EVAPORATION, temperature 22K
|
Resolution 2.20 Å
R-free 0.291
|
|
1DU3
Crystal structure of TRAIL-SDR5
Deposited 2000-01-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain G
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain H
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
Chain I
54–183(130 aa)
Fragment:EXTRACELLULAR DOMAIN
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 4.6;295 K;PEG 1000, Sodium Acetate, Sodium Chloride, pH 4.6, EVAPORATION, temperature 22K
|
Resolution 2.20 Å
R-free 0.291
|
|
1ZA3
The crystal structure of the YSd1 Fab bound to DR5
Deposited 2005-04-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain S
54–183(130 aa)
Fragment:Extra-cellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;292 K;20% PEG 8000, 0.2M MgAcetate, 0.1M NaCacodylate pH 6.2-6.6, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.35 Å
R-free 0.280
|
|
1ZA3
The crystal structure of the YSd1 Fab bound to DR5
Deposited 2005-04-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain R
54–183(130 aa)
Fragment:Extra-cellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;292 K;20% PEG 8000, 0.2M MgAcetate, 0.1M NaCacodylate pH 6.2-6.6, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.35 Å
R-free 0.280
|
|
2H9G
Crystal structure of phage derived Fab BdF1 with human Death Receptor 5 (DR5)
Deposited 2006-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain R
54–183(130 aa)
Fragment:extra cellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;292 K;Crystals from drops containing an equal volume of protein and well solution consisting of 20% PEG 3350, 0.2M Na2HPO4, 0.1 M Bis-Tris, pH 6.1-6.8. The crystals were cryo-protected with well solution supplemented with 20% PEG 200., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.32 Å
R-free 0.282
|
|
2H9G
Crystal structure of phage derived Fab BdF1 with human Death Receptor 5 (DR5)
Deposited 2006-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain S
54–183(130 aa)
Fragment:extra cellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;292 K;Crystals from drops containing an equal volume of protein and well solution consisting of 20% PEG 3350, 0.2M Na2HPO4, 0.1 M Bis-Tris, pH 6.1-6.8. The crystals were cryo-protected with well solution supplemented with 20% PEG 200., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 2.32 Å
R-free 0.282
|
|
3X3F
TRAIL-R2 Extracellular Region Complexed to a Fab fragment from Human Agonist Antibody KMTR2
Deposited 2015-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
54–184(131 aa)
Fragment:UNP residues 54-184
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;7.5% PEG 3350, 75mM calcium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.224
|
|
4N90
Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody
Deposited 2013-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain T
57–182(126 aa)
Fragment:UNP residues 57-182
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.286
|
|
4N90
Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody
Deposited 2013-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain S
57–182(126 aa)
Fragment:UNP residues 57-182
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.286
|
|
4N90
Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody
Deposited 2013-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
57–182(126 aa)
Fragment:UNP residues 57-182
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.286
|
|
4OD2
Crystal structure of the Fab fragment of an anti-DR5 antibody bound to DR5
Deposited 2014-01-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain S
73–183(111 aa)
Fragment:UNP residues 73-183
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;292 K;Protein (7mg/mL in 20 mM Tris-HCl, 150 mM NaCl) was mixed with equal volume of well solution (30% PEG 4K, 0.1 M Tris-HCl pH 8.5, 0.2M MgCl2), VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 3.20 Å
R-free 0.305
|
|
6NHW
Structure of the transmembrane domain of the Death Receptor 5 - Dimer of Trimer
Deposited 2018-12-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
208–242(35 aa)
Fragment:residues 208-242
Chain B
208–242(35 aa)
Fragment:residues 208-242
Chain C
208–242(35 aa)
Fragment:residues 208-242
Chain D
208–242(35 aa)
Fragment:residues 208-242
Chain E
208–242(35 aa)
Fragment:residues 208-242
Chain F
208–242(35 aa)
Fragment:residues 208-242
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 50;Pressure 1
NMR sample composition
0.8 mM [U-13C; U-15N; 85%-2H] Transmembrane Domain of Death Receptor 5, 50 mM DMPC, 100 mM DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
0.8 mM [U-13C; U-15N] Transmembrane Domain of Death Receptor 5, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
0.4 mM [U-15N; U-2H; 15%-13C] Transmembrane Domain of Death Receptor 5, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
6NHY
Structure of the transmembrane domain of the Death Receptor 5 mutant (G217Y) - Trimer Only
Deposited 2018-12-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
208–242(35 aa)
Chain B
208–242(35 aa)
Chain C
208–242(35 aa)
|
Mutation:G217Y
Mutation:G217Y
Mutation:G217Y
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 50;Pressure 1
NMR sample composition
0.8 mM [U-13C; U-15N; 85%-2H] Transmembrane Domain of DR5 Mutant G217Y, 50 mM DMPC, 100 mM DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
0.8 mM [U-13C; U-15N] Transmembrane Domain of DR5 Mutant G217Y, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
0.4 mM [15%-13C; U-15N; H-2H] Transmembrane Domain of DR5 Mutant G217Y, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
6T3J
Dual Epitope Targeting by Anti-DR5 Antibodies
Deposited 2019-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
58–184(127 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;281 K;10% (w/v) PEG 4000
200 mM ammonium sulphate
100 mM Sodium acetate pH 4.6
|
Resolution 3.05 Å
R-free 0.282
|
|
6T3J
Dual Epitope Targeting by Anti-DR5 Antibodies
Deposited 2019-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain J
58–184(127 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;281 K;10% (w/v) PEG 4000
200 mM ammonium sulphate
100 mM Sodium acetate pH 4.6
|
Resolution 3.05 Å
R-free 0.282
|
|
8DPX
Preligand association structure of DR5
Deposited 2022-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
77–184(108 aa)
Chain B
77–184(108 aa)
Chain C
77–184(108 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;310 K;Ionic strength (raw mmCIF value) 50;Pressure 1
NMR sample composition
400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
500 uM [U-100% 15N; U-100% 2H] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
250 uM [U-100% 15N; U-100% 2H] Isotopically mixed DR5 ectodomain, 250 uM [U-100% 13C] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
250 uM [U-100% 13C; U-100% 15N; U-95% 2H] Isotopically mixed DR5 ectodomain, 250 uM DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
500 uM [U-100% 13C; U-100% 15N] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
400 uM [U-100% 15N, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|